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Abstract
Background: The increasing prevalence of diabetes is leading to a rise of eye diseases, augmenting the risk of
sight-threatening complications. The aim of this study was to evaluate prevalence, awareness and practices
regarding eye diseases among patients with diabetes in the canton of Vaud, Switzerland.
Methods: A cohort of 323 patients with diabetes completed a self-administered questionnaire assessing
prevalence, awareness and practices regarding eye diseases, besides health status and quality of care measures.
Descriptive analyses followed by exploratory subgroup analyses and linear regressions were performed to
investigate factors associated with awareness and practices.
Results: While diabetic retinopathy was reported by 40.9% of patients with type 1 diabetes and 9.8% of patients
with type 2 diabetes, 35.8% and 12.6% of all participants reported cataract and glaucoma, respectively. Awareness
that diabetes could damage the eyes was reported by almost all participants; the majority was also aware of the
importance of glycemic control and regular eye examination in preventing eye diseases. In contrast, only 70.5% of
participants underwent an eye examination by an ophthalmologist during the past year. Eye examination was
associated with better patients’ awareness. Barriers mentioned by patients revealed a lack of knowledge about
screening guidelines, in particular regarding the preventive nature of eye examinations.
Conclusions: Despite high levels of awareness regarding diabetic eye diseases, a significant proportion of patients
with diabetes did not report annual eye examination. Both healthcare strategic efforts targeting the promotion of
regular eye examination and initiatives aiming at improving knowledge of screening guidelines should be
encouraged.
Trial registration: ClinicalTrials.gov on 9th July 2013, identifier NCT01902043 (retrospectively registered).
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Background
Diabetes, a major public health problem affecting more
than four hundred million people worldwide [1, 2], is asso-
ciated with macrovascular and microvascular complications
such as cerebrovascular diseases, kidney diseases, neural
damages and eye diseases [3]. Among microvascular com-
plications, vision loss from diabetic retinopathy [4],may be
one of the most devastating complications for affected indi-
viduals. Currently, with the rising prevalence of diabetes
[7], the latter complication emerges as a leading cause of
avoidable visual impairment and blindness worldwide [8].
Additionally, other eye diseases that may compromise vi-
sion, such as cataract [5] and glaucoma [6], appear to in-
crease in prevalence among patients with diabetes [7, 8].
Optimal management of diabetic retinopathy should in-
clude annual screening, adequate control of associated
risk factors and timely treatment [4]. Furthermore, a sig-
nificant element towards an optimal management, which
is often undervalued, is the improvement of awareness
and education among diabetic patients [9, 10]. Focusing
on these parameters could enable actions targeting pre-
ventive strategies more effectively.
Previous studies assessing awareness and practices re-
garding eye diseases in patients with diabetes were
mainly based in low- and middle-income countries,
often reporting poor results [9–24]. Surprisingly, the as-
sociation between poor awareness and/or practices and
diabetic eye diseases has also been reported in high-
income countries [8, 25–27].
Further and broader exploration and improved aware-
ness and practices regarding eye diseases in patients with
diabetes in general, not only focusing on diabetic retin-
opathy, may provide multiple benefits to patients and,
consequently, to national healthcare systems. For ex-
ample, it has been shown that ophthalmologic screening
for patients with diabetes is highly cost-effective, com-
pared to routinely provided medical interventions [28].
Furthermore, it was demonstrated that patients with dia-
betes could develop an expertise in the everyday man-
agement of their condition [29]. Finally, it has been
reported that improving patient awareness of updated
diabetes care recommendations and empowering them
drives to better diabetes outcomes [30].
In that context, the aims of our study were first to
describe eye diseases reported by patients with dia-
betes, second to assess their awareness and practices
related to prevention of diabetic eye disease and, fi-
nally, to investigate potential determinants of patient
awareness. To the best of our knowledge, this is the
first study to evaluate awareness and practices regard-
ing eye diseases among Swiss patients with diabetes,
and one of very few studies conducted in a high-
income country. In addition, whereas most other stud-
ies focused on diabetic retinopathy alone, we opted for
a more comprehensive approach of eye diseases in pa-
tients with diabetes.
Methods
Study setting and study population
The CoDiab-VD cohort was launched in 2011–2012 in
the canton of Vaud (a Swiss region of about 750,000 in-
habitants). Non-institutionalized adults (≥18 years) report-
ing a diagnosis of diabetes for at least one year, residing in
the canton of Vaud, with a sufficient level of French to
understand and complete a self-report questionnaire, and
without cognitive impairment or gestational diabetes were
recruited through community-based pharmacies [31, 32].
Participants are followed-up annually since 2013 by self-
administered paper-based postal questionnaire [32]. From
the 519 patients with diabetes recruited in 2011–2012,
377 could be contacted in 2015, and 323 participants an-
swered to the 2015 follow-up questionnaire and were in-
cluded in our analyses.
Study instrument
Patients’ self-reported outcomes harvested by postal ques-
tionnaire were considered. In 2015, the core questionnaire,
described in detail elsewhere [32], was enriched with a the-
matic module entitled “Eyes and diabetes” that investigated
eye diseases and treatments, eye examinations by an oph-
thalmologist along with their barriers and facilitators, as
well as awareness of risk factors and prevention of diabetic
eye diseases.
Measures
The measures of interest for this study were i) patients’
characteristics and health status: age, gender, nationality
(Swiss, other), education (primary, secondary, tertiary),
civil status (married or living with a partner vs. other),
economic hardship (difficulty in paying bills: yes, no; re-
ceipt of health insurance subsidies: yes, no), smoking
status (current smoker vs. other), physical activity level
using questions from the Swiss Health Survey (physically
inactive vs. other) [33], ii) self-reported health status (ex-
cellent, very good, good, medium, poor), as well as iii)
variables describing participants’ diabetes [type of dia-
betes (type 1, type 2, undetermined), duration of diabetes
at the time of recruitment (≤10 years, >10 years), treat-
ment (oral antidiabetic alone vs. insulin or other antidia-
betic injection)], iv) participants’ membership in the
local diabetes association (yes, no, do not know), v) the
following outcome of care indicators: HbA1c awareness
(yes, no, do not know), HbA1c value among HbA1c-
aware patients, generic and diabetes-specific health-
related quality of life measures (SF-12 physical and
mental component scores – PCS and MCS, score range
0 = worst to 100 = best; Audit of Diabetes-Dependent
Konstantinidis et al. BMC Endocrine Disorders  (2017) 17:56 Page 2 of 11
Quality of Life 19 – ADDQoL, range − 9 = maximum
negative impact of diabetes to +3 = maximum positive im-
pact of diabetes), congruency of care with the Chronic
Care Model (Patient Assessment of Chronic Illness Care
– PACIC score, range 1 = lowest to 5 = highest congru-
ency), and diabetes-related self-efficacy (Stanford Diabetes
Self-Efficacy Scale, range 1 = lowest to 10 = highest self-
efficacy), and also vi) process of care indicators (during
the past 12 months) such as HbA1c check among HbA1c-
aware patients (1×, ≥2×, none, do not know), blood pres-
sure measurement (1×, 2-3×, ≥4×, none, do not know),
lipid profile (yes, no, do not know), diabetic foot examin-
ation by a healthcare professional (yes, no, do not know),
microalbuminuria test (yes, no, do not know), and influ-
enza vaccination (yes, no, do not know); all latter pro-
cesses of care variables were dichotomized (i.e. patients
having had at least one check versus those not having had
any, do not know answers not being considered).
The “Eyes and diabetes” 2015 thematic module tar-
geted prevalence, awareness and practices regarding eye
diseases, as well as barriers and facilitators to regular eye
examination. First, patient-reported prevalence of eye
diseases was measured with a multiple choice question in-
cluding the following responses: diabetic retinopathy;
cataract; age-related macular degeneration; myopia /
hyperopia / astigmatism / presbyopia; other; no eye condi-
tions; do not know; for those reporting diabetic retinop-
athy, treatment received was asked and the following
response categories were available: laser therapy; eye injec-
tion; surgical intervention; other; no treatment; do not
know. Second, we considered awareness, which refers to
patients’ knowledge about diabetic eye diseases, and this
was assessed with questions such as: prior knowledge that
diabetes could damage the eyes (yes, no), knowledge of
risk factors and prevention of diabetic eye diseases based
on the following five items: maintaining good glycemic
control; having regular eye examination by an ophthal-
mologist; maintaining good blood pressure control; main-
taining good lipid control; nothing can be done, it is “bad
luck”; (yes, no, do not know). The expected answers were
“yes” for the four first items and “no” for the last one; this
allowed the calculation of a score (referred to as the
“awareness score” below) – for those answering at least 3
out of 5 items – constructed as the sum of the 5 items
(each correct answer was given 1 point, otherwise 0) and
ranging between 0 (= no correct answer) to 5 (= all an-
swers correct). Then, we considered practices, which re-
fers to the use of services regarding eye care, and was
operationalized as the last eye examination (more pre-
cisely as the last dilated pupil examination of the eye fun-
dus by an ophthalmologist) (0–12 months ago, 13–
24 months ago, more than 24 months ago, never, do not
know). We also asked patients, answering positively to a
filter question on their awareness of the retinal
photography examination, whether they had ever had a
retinal photography examination (yes, without pupil dila-
tation; yes, with pupil dilatation; no; do not know). Finally,
barriers and facilitators to regular eye examination by an
ophthalmologist were also explored with a multiple choice
question: i) barriers (no recommendation from the family
physician or diabetologist; no information about diabetic
eye diseases; no information about retinal screening; no
time; financial reasons; too many other examinations and
medical appointments; fear of the examination, result or
treatment; fear of losing their driving license; discomfort
during the examination (eye drops, dilated pupils); diffi-
culty to find an ophthalmologist; difficulty to go to the
ophthalmologist’s practice; no symptoms or vision prob-
lems; belief that it is not necessary because diabetes is well
controlled; other) and ii) facilitators (recommendation of
healthcare professionals; recommendation of relatives;
feeling obliged to do it; knowledge of its importance;
knowledge of the risks of a diabetes-related affection of
the retina; knowledge of the treatment options; fear of
having their eyes affected; having another eye problem ne-
cessitating an ophthalmologic follow-up).
Statistical analysis
First, descriptive analyses of participants’ characteristics
and eye-related variables were performed: means (SD) or
percentages were computed for continuous or categor-
ical variables respectively, as well as 95% confidence in-
tervals for the prevalence of eye-related variables.
Second, exploratory subgroup analyses were performed
using T-test or chi-squared test, as appropriate. Finally,
linear regressions were used to explore the association
between the awareness score and explanatory variables a
priori hypothesized to be associated with awareness: type
of diabetes, age, gender, education, duration of diabetes
at the time of recruitment, local diabetes association
membership, presence of diabetic retinopathy, and eye
examination by an ophthalmologist during the past two
years. All analyses were performed using Stata 14.1.
Ethical considerations
The study protocol was reviewed and approved by the
Cantonal Ethics Committee of Research on Human Be-
ings of the canton of Vaud (Protocol N° 151/11), and the
CoDiab-VD cohort was registered with ClinicalTrials.-
gov, identifier NCT01902043. Written informed consent
was obtained from all participants, and data are being
kept confidential and anonymous.
Results
Characteristics of participants
Description of the study population is detailed in Table 1.
In summary, mean age of respondents was 66.5 years and
38.7% were women. Whereas the majority (83.3%) reported
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type 2 diabetes, 57.5% were treated with insulin and/or
other anti-diabetic injection. Also, while 18.4% were current
smokers, 31% were physically inactive, and 18.3% declared
being member of the local diabetes association.
Prevalence of eye conditions
As shown in Table 2, eye diseases were widespread among
respondents. Besides common visual defects (i.e. myopia,
hyperopia, astigmatism, presbyopia) that affected 36.2% of
patients, cataract was the most frequently reported eye
disease (35.8%). Whereas glaucoma was mentioned by
12.6% of patients, only 14.2% of patients reported being
affected by diabetic retinopathy, a specific microvascular
complication of diabetes. However, when looking at the
disparity between types of diabetes, it appears that patients
with type 1 diabetes reported being considerably more
frequently affected by retinopathy than those with type 2
diabetes (40.9% vs. 9.8%). For those reporting diabetic ret-
inopathy, this complication was reported to be mainly
treated by laser therapy (75.6%), followed by intraocular
injection (26.8%) and surgical intervention (19.5%). Up to
16% of patients with type 2 diabetes reported not being
treated for their diabetic retinopathy, while this scenario
was not reported by patients with type 1 diabetes. Finally,
we observed that multiple eye diseases affected more often
patients with type 1 diabetes than patients with type 2 dia-
betes (≥3 diseases: 20.9% vs. 4.7%).
Awareness regarding diabetic eye diseases
Regarding patients’ awareness about diabetic eye diseases
and how to prevent them, a significant percentage of
participants (96.0%) had prior knowledge that diabetes
could damage the eyes; in fact, all patients with type 1
diabetes and 95.1% of patients with type 2 diabetes were
Table 1 Participants characteristics
Al a Type 1 Type 2
(n= 323) (n = 44) (n = 269)
Mean (SD) age (years) 66.5 (10.6) 57.4 (14.0) 68.1 (9.3)
Women 38.7% 63.6% 34.9%
Nationality
Swiss 83.5% 74.4% 85.9%
Other 16.5% 25.6% 14.1%
Education
Primary 16.0% 14.3% 15.4%
Secondary 57.6% 54.8% 59.0%
Tertiary 26.4% 31.0% 25.6%
Married or living with partner 65.9% 56.8% 66.5%
Economic hardships
Difficulties in paying bills during the past 12 months 22.8% 34.1% 20.3%
Health insurance subsidies 17.3% 20.5% 16.7%
Member of the local diabetes associationb 18.3% 54.6% 12.7%
Current smoking 18.4% 14.0% 19.6%
Physically inactive 31.0% 29.6% 32.0%
Type of diabetes
Type 1 13.6% - -
Type 2 83.3% - -
Undetermined 3.1% - -
Type of treatment
Oral antidiabetics 42.6% 0.0% 50.8%
Insulin or other antidiabetic injection 57.5% 100% 49.3%
Self-reported health
Excellent/very good 14.9% 21.4% 14.4%
Good 61.3% 64.3% 60.6%
Medium/poor 23.8% 14.3% 25.0%
aThe 10 participants with an undetermined type of diabetes were not included in the subgroup analyses
b“Association Vaudoise du Diabète – AVD”
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aware of this risk. Furthermore, the vast majority of pa-
tients knew the benefit of maintaining good glycemic
control and having regular eye examination by an oph-
thalmologist (98.6% and 97.5%, respectively) (Table 3). In
contrast, benefits of maintaining good blood pressure con-
trol and good lipid control were less known, with
respectively 91.3% and 85.4% of patients perceiving them as
preventive behaviours. Finally a quarter of the participants
answered positively to the item affirming that nothing can
be done to prevent diabetic eye diseases, that’s the result of
“bad luck”.
Practices: Frequency of eye examination
Seven out of ten patients (70.5%) reported having under-
gone an eye examination by an ophthalmologist during
the past 12 months, and 87.0% during the past two years.
Table 2 Prevalence of eye diseases as reported by patients
Alla Type 1 Type 2
(n = 323) (n = 44) (n = 269)
% [CI 95%] % %
Eye diseases b (n = 318) (n = 318) (n = 44) (n = 265)
Diabetic retinopathy 14.2% [10.3%–18.0%] 40.9% 9.8%
Cataract 35.8% [30.5%–41.1%] 40.9% 35.1%
Glaucoma 12.6% [8.9%–16.2%] 11.4% 12.8%
Age-related macular degeneration 4.7% [2.4%–7.1%] 4.5% 4.5%
Myopia, hyperopia, astigmatism, presbyopia 36.2% [30.9%–41.5%] 38.6% 35.5%
Other 2.8% [1.0%–4.7%] 2.3% 3.0%
No 26.7% [21.8%–31.6%] 22.7% 27.9%
Do not know 2.5% [0.8%–4.2%] 2.3% 2.6%
Number of eye diseases reported (n = 310) (n = 310) (n = 43) (n = 258)
0 disease 27.4% - 23.3% 28.7%
1 disease 45.8% - 37.2% 46.5%
2 diseases 20.0% - 18.6% 20.2%
≥ 3 diseases 6.8% - 20.9% 4.7%
Treatment for diabetic retinopathy
(among patients reporting diabetic retinopathy) b (n = 41)
n = 41) n = 15) (n = 25)
Laser therapy 75.6% [61.9%–89.3%] 100.0% 60.0%
Eye injection 26.8% [12.7%–41.0%] 33.3% 24.0%
Surgical intervention 19.5% [6.8%–32.2%] 26.7% 16.0%
Other 2.4% [−2.5%–7.4%] 0.0% 4.0%
Retinopathy without having had treatment 9.8% [0.3%–19.2%] 0.0% 16.0%
Do not know 2.4% [−2.5%–7.4%] 0.0% 4.0%
aThe 10 participants with an undetermined type of diabetes were not included in the subgroup analyses
bMultiple answers allowed
Table 3 Patients’ awareness about what can be done to prevent the occurrence or deterioration of diabetic eye diseases
(n) Expected answer % of correct answers
Prevention meansa
Maintaining good glycemic control (291) Yes 98.6%
Having regular eye examination by an ophthalmologist (284) Yes 97.5%
Maintaining good blood pressure control (288) Yes 91.3%
Maintaining good lipid control (274) Yes 85.4%
Nothing can be done, it is “bad luck” (236) No 75.9%
Mean knowledge score [95%CI]b (292) 4.1 [4.0–4.2]
aResults for patients having answered at least 3 out of the 5 items
bThe score was constructed as the sum of the 5 items – for those answering to at least 3 out of 5 items; each correct answer was given 1 point, otherwise 0;
range between 0 (= no correct answer) to 5 (= all answers correct)
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Moreover, a very small proportion (3.7%) of respondents
stated never having seen an ophthalmologist to screen for
diabetic eye diseases. Furthermore, the proportion of pa-
tients visiting an ophthalmologist during the past two
years was higher for patients with type 1 diabetes than for
those with type 2 diabetes (95.5% vs. 85.5%). In addition,
whereas retinal photography examination was known by
63.3% of patients, 83.9% of those answering positively to
the previous question reported ever having undergone this
examination, with or without pupil dilatation.
Patients who did not report an eye examination by an
ophthalmologist during the past two years (13.0% of the
total sample) differed from the rest of the sample on several
points, while being similar regarding age, gender, education
level and type of diabetes (Table 4). First, participants who
did not report an eye examination during the past two years
were less likely to report eye diseases (p = 0.001) or taking
insulin or another antidiabetic injection (p = <0.001). More-
over, while they obtained a better disease-specific quality of
life score (ADDQoL, p = 0.011), the care they reported was
less congruent with the Chronic Care Model (PACIC:
p = <0.001) than patients reporting an eye examination
during the past two years. They also were less likely to be
members of the local diabetes association (p = 0.009) or to
Table 4 Subgroup analyses: comparison of patients visiting, or not, an ophthalmologist during the past 2 years
Visit to an ophthalmologist during the past 2 years Yes (n = 280) No (n = 42)
n Mean (SD) or % Mean or % p-valuea
Age 322 66.8 (10.5) 64.7 (11.5) 0.244
Gender 322
Women 40.0% 31.0% 0.262
Men 60.0% 69.1%
Education 317
Primary 14.9% 23.8% 0.172
Secondary 59.6% 45.2%
Tertiary 25.5% 31.0%
Type of diabetes c 322
Type 1 15.0% 4.8% 0.153c
Type 2 81.8% 92.9%
Undetermined 3.2% 2.4%
Type of treatment 321
Oral antidiabetic 37.9% 73.2% <0.001
Insulin or other antidiabetic injection 62.1% 26.8%
Member of the local diabetes association 321 20.1% 7.1% 0.053 c
Number of eye diseases reported 310 1.2 (1.0) 0.6 (0.6) 0.001
HbA1C valueb 174 7.3 (1.1) 6.8 (0.8) 0.313
ADDQoL global score 322 −1.5 (1.6) −0.8 (1.1) 0.011
SF-12 PCS 312 43.5 (10.0) 44.8 (9.6) 0.440
SF-12 MCS 311 46.4 (11.1) 45.9 (10.2) 0.771
PACIC global score 316 2.8 (1.0) 2.2 (0.8) <0.001
Stanford self-efficacy score 316 7.8 (1.6) 7.6 (1.9) 0.610
HbA1C awareness 303 91.3% 66.7% <0.001
HbA1C checkb 262 99.2% 92.0% 0.047 c
Blood pressure measurement 315 99.3% 95.2% 0.087 c
Lipid profile 311 97.4% 95.2% 0.349 c
Diabetic foot examination 313 68.6% 45.2% 0.003
Microalbuminuria test 283 82.9% 71.1% 0.083
Influenza vaccination 314 67.7% 45.2% 0.005
aP-value from t-tests or Chi2/Fisher’s exact test
bAmong HbA1C-aware patients
cCalculated with Fisher’s exact test
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be aware of what HbA1c is (p = <0.001). Finally, they re-
ported having received globally less preventive care
compared to the other respondents; some of these
comparisons being statistically significant (HbA1c
check: p = 0.047, foot examination: p = 0.003, influenza
vaccination: p = 0.005).
Barriers and facilitators to regular eye examination
We then explored, with multiple choice questions, the
reasons for patients to undergo or not a regular eye
examination by an ophthalmologist (Table 5). The three
main barriers to undergoing a regular eye examination
mentioned by patients not screened during the past
12 months were the fact that they had no visual symp-
tom or vision problem (32.9%), they found it unneces-
sary because their diabetes was well controlled (30.0%),
and they did not get recommendations from their family
physician or diabetologist (30.0%). Conversely, the three
main facilitators for visiting regularly an ophthalmologist
for eye screening, mentioned by patients regularly
screened, were the fact that healthcare professionals rec-
ommended it (54.8%), that they were aware of the
importance of regular controls (38.0%) as well as of the
risks of diabetes-related affection of the retina (33.8%).
Exploratory analyses: Factors associated with patients’
awareness score
The exploratory linear regression analyses investigating
the determinants of patients’ knowledge about preven-
tion of diabetic eye diseases revealed that only one vari-
able was associated with the awareness score: eye
examination performed during the past two years
(p = 0.005). No association was found with the seven
others variables of the model (age, gender, education,
type of diabetes, duration of diabetes at recruitment,
member of the local diabetes association, and presence
of diabetic retinopathy).
Discussion
In this study, we explored patients’ reported prevalence,
awareness and practices regarding eye diseases among
patients with diabetes, as well as barriers and facilitators
to regular eye examination. We found that eye diseases
were frequent, especially among patients with type 1
Table 5 Barriers and facilitators to regular eye examination by an ophthalmologista
% [CI 95%]
Facilitatorsb (n = 305)
Recommendation of healthcare professionals 54.8% [49.1%–60.4%]
Recommendation of relatives 2.3% [0.6%–4.0%]
Feeling obliged to do it 9.8% [6.5%–13.2%]
Knowledge of its importance 38.0% [32.6%–43.5%]
Knowledge of the risks of a diabetes-related affection of the retina 33.8% [28.4%–39.1%]
Knowledge of the treatment options 11.8% [8.2%–15.4%]
Fear of having their eyes affected 22.3% [17.6%–27.0%]
Having another eye problem necessitating an ophthalmologic follow-up 14.4% [10.5%–18.4%]
Barriersc (n = 70)
No recommendation from the family physician or diabetologist 30.0% [19.0%–41.0%]
No information about diabetic eye diseases 7.1% [1.0%–13.3%]
No information about retinal screening 2.9% [−1.1%–6.9%]
No time 10.0% [2.8%–17.2%]
Financial reasons 4.3% [−0.6%–9.1%]
Too many other examinations and medical appointments 4.3% [−0.6%–9.1%]
Fear of the examination, result or treatment 1.4% [−1.4%–4.3%]
Fear of losing their driving license 0.0% -
Discomfort during the examination (eye drops, dilated pupils) 1.4% [−1.4%–4.3%]
Difficulty to find an ophthalmologist 4.3% [−0.6%–9.1%]
Difficulty to go to the ophthalmologist’s practice 4.3% [−0.6%–9.1%]
No symptoms or vision problems 32.9% [21.6%–44.1%]
Belief that it is not necessary because diabetes is well controlled 30.0% [19.0%–41.0%]
aMultiple choice questions
bResults for patients having reported at least one eye examination (no time frame)
cResults for patients having not reported an eye examination during the past 12 months
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diabetes. We also noticed that the majority of patients
were aware of the positive influence of good glycemic
control and of regular eye examinations by an ophthal-
mologist on the prevention of diabetic eye diseases,
while the benefits of good blood pressure or good lipid
controls were less well known. Also, whereas most par-
ticipants underwent regular eye examinations by an oph-
thalmologist, one third of patients did not visit an
ophthalmologist during the last year, mainly because
they did not seem to be aware of the importance of pre-
ventive examinations. Finally, our exploratory model re-
vealed that regular eye examination was positively
associated with patients’ awareness of ocular preventive
measures.
Diabetes and eye diseases
Diabetes has been associated with the development of
various eye diseases [34] including primarily retinopathy
[4], but also cataract [5] and glaucoma. [6] More specif-
ically, epidemiological studies have shown that the prob-
ability of retinal complications was higher in patients
with type 1 than with type 2 diabetes: potentially vision-
threatening retinal changes developed over time in up to
50% of patients with type 1 diabetes and 30% of those
with type 2 diabetes [35]. In our study, we found that
diabetic retinopathy, the leading cause of vision loss in
adults aged 20–74 years [36], was reported by 40.9% of
patients with type 1 diabetes and only 9.8% of patients
with type 2 diabetes. Considering that diabetic retinop-
athy is generally present in about 30% of patients with
type 2 diabetes [37], different hypotheses could explain
this discrepancy. One could be that diabetic retinopathy
is underestimated due to the fact that a percentage of
patients had no eye examination during the last year.
This inconsistency may also simply reflect poor know-
ledge of diabetic retinopathy status, an issue already
shown in other studies [25, 27]. Additionally, it has been
suggested that prevalence of retinopathy is likely under-
estimated in patients’ perceived history of diabetic retin-
opathy [38]. Moreover, considering that the vast
majority of participants reporting diabetic retinopathy
also reported having received ocular treatment for this
condition, we may hypothesize that some participants
falsely assume that they only present diabetic retinop-
athy if treatment is needed; for example in the presence
of proliferative diabetic retinopathy or macular edema,
therefore leading patients to under-report simple dia-
betic retinopathy. Another explanation might be that pa-
tients do not understand well what specialist physicians
do and/or say during/after eye examination, and are
consequently not well aware of their eye conditions.
Correlations between patients and physicians reported
annual eye and foot examinations suggest such an ex-
planation [39]. The last explanation could be that our
sample is not representative of the population of patients
with diabetes.
We also found that cataract was reported by 35.8% of
the participants, and by 40.9% of patients with type 1
diabetes despite the younger mean age of this group
(57.4 years for patients with type 1 diabetes vs. 68.1 years
for patients with type 2 diabetes). Epidemiologic studies
have demonstrated that cataract is a common cause of
visual impairment in patients with diabetes [40–42], and
that patients with diabetes are 2–5 times more likely to
develop cataract than their non-diabetic counterparts
[42]. Since cataracts occur at an earlier age in patients
with diabetes, it leads to a visual loss with a significant
impact on the working population [5].
Finally, our results also showed that one in ten pa-
tients reported glaucoma; such results are in line with
recent evidence suggesting that patients with diabetes
are at greater risk of glaucoma [6], although it should be
mentioned that the association between diabetes and
glaucoma remains controversial for some authors [35].
This non-negligible percentage dictates the need for at
least a basic glaucoma screening in patients with dia-
betes during their routine eye examination. In addition,
as glaucoma evolves silently, with potentially irreversible
and devastating visual loss when untreated, it may be
wise to broaden the diabetes education perspective and
include all significant diabetic eye diseases instead of fo-
cusing solely on diabetic retinopathy. .
Awareness regarding diabetic eye diseases
In the present study, almost all patients with diabetes
were aware that diabetes could damage the eyes, which
is coherent with results from other studies conducted in
high-income countries. For example, Schmid et al. re-
ported that 96% of Australian patients with diabetes
were aware that diabetes could be sight-threatening [43],
and more than 98% of Japanese patients with type 2 dia-
betes were aware that diabetes could be related to eye
damage [27].
Interestingly, our exploratory analyses revealed that
eye examination by an ophthalmologist during the past
2 years was significantly associated with better awareness
regarding diabetic eye diseases. This is not surprising
considering that comprehensive eye examinations gener-
ally include patients’ education regarding ocular compli-
cations and guidance about preventive measures. These
findings emphasize the need to promote regular exami-
nations by an eye specialist.
Practices: Frequency of eye examination
Despite a high level of awareness regarding diabetic eye dis-
eases, about one third and one eighth of the participants
did not report having had an eye examination performed
by an ophthalmologist during the past 12 and 24 months,
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respectively. This divergence raises the question of the rea-
sons for patients not to more frequently report undergoing
eye examination. Our analysis of barriers and facilitators to
regular eye examination provided some answers. Guidelines
for the screening of diabetic retinopathy clearly state that,
whether or not patients present ocular symptoms or un-
stable diabetes (i.e. poor glycemic control), a yearly eye
examination is required since retinopathy may evolve si-
lently [44]. However, one third of our participants reporting
suboptimal screening practices believed that only the pres-
ence of ocular symptoms justifies an eye examination and
one third that stable diabetes is enough to prevent diabetic
eye diseases. Analogous results have been reported by
others, with the main mentioned reason for skipping exam-
ination being the patients’ belief that they did not suffer
from diabetic retinopathy [27]. It appears that patients tend
to ignore the essentially preventive nature of regular eye
examination, hence the necessity for healthcare profes-
sionals to emphasise this aspect with patients in the future.
The physicians’ potential role in improving practices also
emerged from another barrier mentioned by one third of
participants reporting insufficient eye examination: the ab-
sence of recommendations from their physician (family
physician or diabetologist). The reinforcement of pre-
vention messages delivered by physicians is required since
appropriate guidance and information by primary care phy-
sicians alongside patient education and recommendations
on eye health have been shown to be associated with higher
adherence to screening guidelines [38, 45]. Better results
could even be achieved knowing that physicians can posi-
tively impact screening rates by increasing patient referrals
to eye specialists [39, 46].
Considering that the proportion of patients suffering
from preventable eye diseases continues to rise and that
screening for diabetic eye disease is one of the most cost-
effective medical interventions in ophthalmology, initia-
tives aiming at improving adherence to screening recom-
mendations are warranted [46]. To achieve this goal, both
patients’ and healthcare professionals’ knowledge about
screening guidelines need to be strengthened.
Strengths and limitations
The strengths of our study lie in the fact that we ex-
plored the prevalence, awareness and practices regarding
eye diseases in a population-based cohort of patients
with diabetes whereas these concepts were previously
investigated mainly in the context of ophthalmic consul-
tations and limited to diabetic retinopathy. Also, it con-
sidered several key measures and outcomes of interest in
the field of diabetes care. Nevertheless our results need
to be interpreted in consideration of the following limi-
tations. First, they were based on patients’ self-reported
data, which may be prone to recall as well as desirability
bias. However, previous analyses of the Codiab-VD
cohort data showed good agreement between patients-
and physician-reported outcomes [47]. In addition, self-
reported patient-centered outcomes are increasingly
considered as key in the evaluation of patients’ care and
therefore need to be used. Secondly, despite the fact that
the Co-Diab-VD participants may not be representative
of the general population of patients with diabetes, pa-
tients recruited in the CoDiab-VD cohort appeared to
share similar characteristics with participants in other
studies conducted in the same region [48, 49].
Conclusion
In conclusion, the level of awareness regarding diabetic eye
diseases appeared to be relatively high in patients with dia-
betes residing in the canton of Vaud, Switzerland, while
there is still room for improvement in diabetic eye diseases
screening practices. Barriers mentioned by patients revealed
their lack of knowledge about screening guidelines, in par-
ticular regarding the preventive nature of eye examina-
tions. Consequently, diabetes-related ocular screening
guidelines for patients and healthcare professionals
should be promoted in order to reduce patients’ mis-
conceptions and help them change practices for earlier
detection of diseases and, finally, reduce the risk of
sight-threatening complications.
Acknowledgments
We wish to thank all patients with diabetes who participated in the the
CoDiab-VD cohort. We also thank all partners and members of the working
group for their collaboration. We thank Mrs. Lucienne Boujon for copy edit-
ing the manuscript.
Funding
This study was funded by the Department of Public Health of the canton of
Vaud (“Programme cantonal Diabète”). Isabelle Peytremann-Bridevaux was
supported by a grant from the Swiss National Science Foundation [PROSPER
N° 32333B-123,817 and N°32333B-139,789] up to July 2013 and is currently
supported by the Swiss School of Public Health + [Assistant Professorship
grant]. The funders had no role in study design, data collection, analysis and
interpretation, decision to publish results, or preparation of the manuscript.
Availability of data and materials
The data are available from the corresponding author upon request.
Consent to publish
Not applicable.
Authors’ contributions
LK and TC had equal contribution in the preparation of this article and both
qualify to be considered first authors on that paper. LK, TC, EA, and EZ were
involved in the design of this study; TC and EZ analyzed the data, LK, TC, IPB
interpreted the results; LK and TC wrote the manuscript; EA, LC, IHT, EZ, IPB
edited and revised the manuscript. IPB conceived and supervised the study.
All authors read and approved the final manuscript.
Ethics approval and consent to participate
The study protocol was reviewed and approved by the Cantonal Ethics
Committee of Research on Human Beings of the canton of Vaud (Protocol N
° 151/11), and the CoDiab-VD cohort was registered with ClinicalTrials.gov,
identifier NCT01902043. Written informed consent was obtained from all par-
ticipants, and data are being kept confidential and anonymous.
Konstantinidis et al. BMC Endocrine Disorders  (2017) 17:56 Page 9 of 11
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Jules Gonin University Eye Hospital, University of Lausanne, Avenue de
France 15 - Case Postale 5143 - 1000 Lausanne 2, Lausanne, Switzerland.
2Institute of Social and Preventive Medicine (IUMSP), Lausanne University
Hospital and University of Lausanne, Lausanne, Switzerland. 3Private Practice,
Morges, Switzerland. 4Public Health Service, Department of Health and Social
Action, Canton of Vaud, Lausanne, Switzerland.
Received: 28 February 2017 Accepted: 29 August 2017
References
1. Zhou BLY, Hajifathalian K, Bentham J, Di Cesare M, Danaei G, Bixby H.
Worldwide trends in diabetes since 1980: a pooled analysis of 751
population-based studies with 4.4 million participants. Lancet (London
England). 2016;387(10027):1513–30. https://doi.org/10.1016/s0140-
6736(16)00618-8.
2. International-Diabetes-Federation. Diabetes Atlas. 2015.
3. Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev.
2013;93(1):137–88. https://doi.org/10.1152/physrev.00045.2011.
4. Ting DS, Cheung GC, Wong TY. Diabetic retinopathy: global prevalence,
major risk factors, screening practices and public health challenges: a
review. Clinical & experimental ophthalmology. 2016;44(4):260–77. https://
doi.org/10.1111/ceo.12696.
5. Javadi MA, Zarei-Ghanavati S. Cataracts in diabetic patients: a review article.
Journal of ophthalmic & vision research. 2008;3(1):52–65.
6. Song BJ, Aiello LP, Pasquale LR. Presence and risk factors for glaucoma in
patients with diabetes. Current diabetes reports. 2016;16(12):124. https://doi.
org/10.1007/s11892-016-0815-6.
7. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of
diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14. https://
doi.org/10.1016/j.diabres.2009.10.007.
8. Sabanayagam C, Yip W, Ting DS, Tan G, Wong TY. Ten emerging trends in
the epidemiology of diabetic retinopathy. Ophthalmic Epidemiol. 2016;23(4):
209–22. https://doi.org/10.1080/09286586.2016.1193618.
9. Shukla R, Gudlavalleti MV, Bandyopadhyay S, et al. Perception of care and
barriers to treatment in individuals with diabetic retinopathy in India: 11-city
9-state study. Indian journal of endocrinology and metabolism. 2016;
20(Suppl 1):S33–41. https://doi.org/10.4103/2230-8210.179772.
10. Al Zarea BK. Knowledge, Attitude and Practice of Diabetic Retinopathy
amongst the Diabetic Patients of AlJouf and Hail Province of Saudi Arabia.
Journal of clinical and diagnostic research : JCDR. 2016; 10(5):Nc05–8. doi:
https://doi.org/10.7860/jcdr/2016/19568.7862
11. Kizor-Akaraiwe NN, Ezegwui IR, Oguego N, Uche NJ, NA I, Shiweobi J.
Prevalence, awareness and determinants of diabetic retinopathy in a
screening Centre in Nigeria. J Community Health. 2016;41(4):767–71. https://
doi.org/10.1007/s10900-016-0151-4.
12. Hussain R, Rajesh B, Giridhar A, et al. Knowledge and awareness about
diabetes mellitus and diabetic retinopathy in suburban population of a
south Indian state and its practice among the patients with diabetes
mellitus: a population-based study. Indian J Ophthalmol. 2016;64(4):272–6.
https://doi.org/10.4103/0301-4738.182937.
13. Thapa R, Bajimaya S, Paudyal G, et al. Population awareness of diabetic eye
disease and age related macular degeneration in Nepal: the Bhaktapur retina
study. BMC Ophthalmol. 2015;15:188. https://doi.org/10.1186/s12886-015-0175-z.
14. Islam FM, Chakrabarti R, Islam SZ, Finger RP, Critchley C. Factors associated
with awareness, attitudes and practices regarding common eye diseases in
the general population in a Rural District in Bangladesh: the Bangladesh
population-based diabetes and eye study (BPDES). PLoS One. 2015;10(7):
e0133043. https://doi.org/10.1371/journal.pone.0133043.
15. Liu L, Chen L. Awareness of diabetic retinopathy is the key step for early
prevention, diagnosis and treatment of this disease in China. Patient Educ
Couns. 2014;94(2):284–5. https://doi.org/10.1016/j.pec.2013.10.026.
16. Cetin EN, Zencir M, Fenkci S, Akin F, Yildirim C. Assessment of awareness of
diabetic retinopathy and utilization of eye care services among Turkish
diabetic patients. Primary care diabetes. 2013;7(4):297–302. https://doi.org/
10.1016/j.pcd.2013.04.002.
17. Thapa R, Paudyal G, Maharjan N, Bernstein PS. Awareness of diabetic
retinopathy among diabetic patients in Nepal. Acta Ophthalmol. 2012;90(3):
e242. https://doi.org/10.1111/j.1755-3768.2011.02163.x.
18. Tajunisah I, Wong P, Tan L, Rokiah P, Reddy S. Awareness of eye
complications and prevalence of retinopathy in the first visit to eye clinic
among type 2 diabetic patients. International journal of ophthalmology.
2011;4(5):519–24. https://doi.org/10.3980/j.issn.2222-3959.2011.05.12.
19. Addoor KR, Bhandary SV, Khanna R, et al. Assessment of awareness of
diabetic retinopathy among the diabetics attending the peripheral diabetic
clinics in melaka, malaysia. Med J Malaysia. 2011;66(1):48–52.
20. Muecke JS, Newland HS, Ryan P, et al. Awareness of diabetic eye disease
among general practitioners and diabetic patients in Yangon, Myanmar.
Clinical & experimental ophthalmology. 2008;36(3):265–73. https://doi.org/
10.1111/j.1442-9071.2008.01724.x.
21. Silver K, Williams M, Macario E. The National eye Health Education Program:
increasing awareness of diabetic eye disease among American Indians and
Alaska natives. Ethnicity & disease. 2006;16(4):920–5.
22. Caliskan D, Ozdemir O, Ocaktan E, Idil A. Evaluation of awareness of
diabetes mellitus and associated factors in four health center areas.
Patient Educ Couns. 2006;62(1):142–7. https://doi.org/10.1016/j.pec.
2005.06.018.
23. Verma L, Elankumaran P, Prakash G, Venkatesh P, Tewari HK. Awareness of
diabetic retinopathy among diabetics. Indian J Ophthalmol. 2002;50(4):355.
24. Trento M, Bajardi M, Borgo E, et al. Perceptions of diabetic retinopathy and
screening procedures among diabetic people. Diabetic medicine : a journal
of the British Diabetic Association. 2002;19(10):810–3.
25. Bressler NM, Varma R, Doan QV, et al. Underuse of the health care system
by persons with diabetes mellitus and diabetic macular edema in the
United States. JAMA ophthalmology. 2014;132(2):168–73. https://doi.org/10.
1001/jamaophthalmol.2013.6426.
26. Huang OS, Tay WT, Ong PG, et al. Prevalence and determinants of
undiagnosed diabetic retinopathy and vision-threatening retinopathy in a
multiethnic Asian cohort: the Singapore epidemiology of eye diseases
(SEED) study. Br J Ophthalmol. 2015;99(12):1614–21. https://doi.org/10.1136/
bjophthalmol-2014-306492.
27. Funatsu H, Hori S, Shimizu E, Nakamura S. Questionnaire survey on periodic
ocular examination in Japanese diabetic patients. Am J Ophthalmol. 2003;
136(5):955–7.
28. Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic
retinopathy. Ann Intern Med. 1996;124(1 Pt 2):164–9.
29. Paterson B, Thorne S. Developmental evolution of expertise in diabetes self-
management. Clin Nurs Res. 2000;9(4):402–19.
30. Colagiuri R. The optometrist's role in the multidisciplinary diabetes team:
towards a more holistic approach. Clinical & experimental optometry. 1999;
82(2–3):55–8.
31. Peytremann-Bridevaux I, Bordet J, Santschi V, Collet TH, Eggli M, Burnand B.
Community-based pharmacies: an opportunity to recruit patients?
International journal of public health. 2013; https://doi.org/10.1007/s00038-
012-0383-8.
32. Zuercher E, Bordet J, Burnand B, Peytremann-Bridevaux I. CoDiab-VD:
protocol of a prospective population-based cohort study on diabetes care
in Switzerland. BMC Health Serv Res. 2015;15:329. https://doi.org/10.1186/
s12913-015-0991-0.
33. Ichhpujani P, Bhartiya S, Kataria M, Topiwala P. Knowledge, attitudes and
self-care practices associated with glaucoma among hospital personnel in a
tertiary Care Center in North India. Journal of current glaucoma practice.
2012;6(3):108–12. https://doi.org/10.5005/jp-journals-10008-1116.
34. Khan A, Petropoulos IN, Ponirakis G, Malik RA. Visual complications in
diabetes mellitus: beyond retinopathy. Diabetic medicine : a journal of the
British Diabetic Association. 2016; https://doi.org/10.1111/dme.13296.
35. Sayin N, Kara N, Pekel G. Ocular complications of diabetes mellitus. World J
Diabetes. 2015;6(1):92–108. https://doi.org/10.4239/wjd.v6.i1.92.
36. Cheung N, Tikellis G, Wang JJ. Diabetic retinopathy. Ophthalmology. 2007;
114(11):2098–2099; author reply 9. https://doi.org/10.1016/j.ophtha.2007.07.010.
37. Nentwich MM, Ulbig MW. Diabetic retinopathy - ocular complications of
diabetes mellitus. World J Diabetes. 2015;6(3):489–99. https://doi.org/10.
4239/wjd.v6.i3.489.
Konstantinidis et al. BMC Endocrine Disorders  (2017) 17:56 Page 10 of 11
38. Sundling V, Gulbrandsen P, Jervell J, Straand J. Care of vision and ocular
health in diabetic members of a national diabetes organization: a cross-
sectional study. BMC Health Serv Res. 2008;8:159. https://doi.org/10.1186/
1472-6963-8-159.
39. Schoenfeld ER, Greene JM, SY W, Leske MC. Patterns of adherence to
diabetes vision care guidelines: baseline findings from the diabetic
retinopathy awareness program. Ophthalmology. 2001;108(3):563–71.
40. Klein BE, Klein R, Moss SE. Prevalence of cataracts in a population-based
study of persons with diabetes mellitus. Ophthalmology. 1985;92(9):1191–6.
41. Klein R, Klein BE, Moss SE. Visual impairment in diabetes. Ophthalmology.
1984;91(1):1–9.
42. Klein BE, Klein R, Moss SE. Incidence of cataract surgery in the
Wisconsin epidemiologic study of diabetic retinopathy. Am J
Ophthalmol. 1995;119(3):295–300.
43. Schmid KL, Schmid LM, Pedersen C. Knowledge of the ocular effects of
diabetes among the general population of Australia and the members of
Diabetes Australia. Clinical & experimental optometry. 2003;86(2):91–103.
44. Diabetic Retinopathy Preferred Practice Patterns - Updated 2016 [database
on the Internet]2016. Available from: https://www.aao.org/preferred-
practice-pattern/diabetic-retinopathy-ppp-updated-2016.
45. Dervan E, Lillis D, Flynn L, Staines A, O'Shea D. Factors that influence the
patient uptake of diabetic retinopathy screening. Ir J Med Sci. 2008;177(4):
303–8. https://doi.org/10.1007/s11845-008-0192-5.
46. Fathy C, Patel S, Sternberg P, Jr., Kohanim S. Disparities in adherence to
screening guidelines for diabetic retinopathy in the United States: a
comprehensive review and guide for future directions. Semin Ophthalmol
2016; 31(4):364–377. doi:https://doi.org/10.3109/08820538.2016.1154170.
47. Collet TH, Taffe P, Bordet J, Burnand B, Peytremann-Bridevaux I.
Reproducibility of diabetes quality of care indicators as reported by patients
and physicians. Eur J Pub Health. 2014;24(6):1004–9. https://doi.org/10.1093/
eurpub/cku011.
48. Kaiser A, Vollenweider P, Waeber G, Marques-Vidal P. Prevalence, awareness
and treatment of type 2 diabetes mellitus in Switzerland: the CoLaus study.
Diabetic medicine : a journal of the British Diabetic Association. 2012;29(2):
190–7. https://doi.org/10.1111/j.1464-5491.2011.03422.x.
49. Sebo P, Abetel G, STalder H, Bovier PA. Importance of lifestyle counseling by
primary care physicians for diabetic patients. Swiss Med Wkly. 2006;136:566–73.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Konstantinidis et al. BMC Endocrine Disorders  (2017) 17:56 Page 11 of 11
